RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. OncoLens

OncoLens

OncoLens is the multidisciplinary cancer care platform for tumor boards, registry automation, AI patient identification, and oncology analytics.

Latest funding

$16M Series B+ ·

Led by BIP Capital · Source: startupintros.com

Total raised: $24.6M across 3 sourced rounds

All 3 rounds ↓
Website: oncolens.com.
X: @OncoLens · 458 followers.
LinkedIn: linkedin.com.
Sectors: Health Care, Information Technology, Medical, Oncology.
Stage: Series B+.
Based in: Atlanta, United States.
Total raised: $24.6M in 3 sourced rounds.
Last round: Oct 24, 2024 · 753 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

X account@OncoLens · created Mar 27, 2017 (9 years old) · 458 followers
Website registeredJun 25, 2015 (11 years old)
TIMELINE · MONEY RAISED

OncoLens | 1370 days from website to first raise on record

@OncoLens·Raised $25M in 3 sourced rounds·2 signals before the first raise
$6.2M$12M$18M$25MJULJAN 2017JULJAN 2020JULJAN 2023JULJAN 2026$25M||WEBSITE CREATED · JUN 25, 2015||X ACCOUNT CREATED @ONCOLENS · MAR 27, 2017$1.35M Seed · Mar 26, 2019$1.35M SEED · MAR '19$7.25M Series A · Jan 13, 2021$7.25M A · JAN '21$16M Series B+ · Oct 24, 2024$16M B+ · OCT '24

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$16MBBIP Capitalstartupintros.com
Series A$7.25M—startupintros.com
Seed$1.35M—startupintros.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like OncoLens

Other companies backed by BIP Capital

BIP Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oncolens (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy